protein recombinant TB vaccine (Hanavax)

N/A

Report date: 2025/01/26 16:50:29

Base Information

Drug Nameprotein recombinant TB vaccine (Hanavax)

Drug Alias NameTB vaccine (Hanavax)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHanavax Inc

China Registration ClassN/A

Develop Information

Active CompaniesHanavax Inc

Inactive CompaniesN/A

Active IndicationsTuberculosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A